Propanc Biopharma, Inc. Share Price
NASDAQ: PPCB | Micro CapPropanc Biopharma, Inc. Stock Performance
Propanc Biopharma, Inc. Share Price Today
As of 9 October 2026, Propanc Biopharma, Inc.'s share price is $0.47. The stock opened at $0.47, compared to its previous close of $0.49. During today's trading session, Propanc Biopharma, Inc.'s share price traded between $0.47 and $0.47, with an average price of $0.47. Over the past 52 weeks, the stock has recorded a high of $6.79 and a low of $0.06. In terms of performance, Propanc Biopharma, Inc.'s share price has risen by 360.88% over the last six months and is down 61.78% on a year-on-year basis.
Propanc Biopharma, Inc. Share Price Chart
Propanc Biopharma, Inc. Quarterly Profit & Loss
All figures in USD
Propanc Biopharma, Inc. Annual Profit & Loss
All figures in USD
About Propanc Biopharma, Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Propanc Biopharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.49 | $0.47 | -6.00% |
Sep 2026 | $1.24 | $0.50 | -77.27% |
Aug 2026 | $1.15 | $2.20 | +120.00% |
Jul 2026 | $1.49 | $1.00 | -35.90% |
Jun 2026 | $1.84 | $1.56 | -10.60% |
May 2026 | $0.10 | $1.75 | +1,610.78% |
Apr 2026 | $0.11 | $0.10 | -8.93% |
Mar 2026 | $0.18 | $0.11 | -42.56% |
Feb 2026 | $0.22 | $0.20 | -11.36% |
Jan 2026 | $0.57 | $0.22 | -58.96% |
Dec 2025 | $1.09 | $0.54 | -37.89% |
Nov 2025 | $1.14 | $0.86 | -29.84% |